Abstract
Arsenic is a ubiquitous environmental contaminant that causes cardiovascular diseases (CVDs) and diabetes. Metabolic syndrome (MeS) is a cluster of conditions associated with the future risk of CVDs and diabetes. Although CVDs are the major causes of arsenic-related mortality, the association between arsenic exposure and MeS remains elusive. Recently, we have reported that arsenic exposure increases hyperglycemia and insulin resistance with greater susceptibility in females than in males. Therefore, we explored the associations of arsenic exposure with the risk of MeS and its components focusing on gender differences. MeS was defined by the modified NCEP ATP III guidelines. A total of 569 adults were recruited from high- and low-arsenic-exposure areas in Bangladesh. Arsenic concentrations in drinking water, hair, and nails were determined as exposure markers. Among 569 subjects, 156 were found to have MeS. Levels of arsenic and the components of MeS were significantly higher in MeS group than those in non-MeS group. Prevalence and odds ratios (ORs) of MeS were increased with increasing exposure to arsenic showing more precise dose-dependent association in women than in men. Except hypertriglyceridemia, the changes in ORs for other components of MeS such as hyperglycemia, hypo-high-density lipoprotein-cholesterolemia, hyper-systolic blood pressure, and abdominal obesity with arsenic exposure were more pronounced in women than in men. Thus, the higher risk of arsenic-related MeS in women than in men suggests a greater susceptibility of women to CVDs that warrant more future investigations on the gender-based distinct pathophysiologic mechanisms of arsenic-related CVDs and diabetes.
This is a preview of subscription content, log in via an institution to check access.
Abbreviation; L, M, H: low, moderate, and high groups of water As, respectively. Associations of water As with the risk of MeS, hyperglycemia, hypertriglyceridemia, hypo-HDL-cholesterolemia, hyper-SBP, hyper-DBP, and abdominal obesity in women and men are shown. ORs adjusted by age and BMI for women; age, BMI, and smoking (non-smoker used as referent) for men. As levels in water: low (0.03–10.91 μg/L), moderate (10.92–127 μg/L), and high (127.01–1006.7 μg/L). Log10 transformed values of OR were used. *p < 0.05, **p < 0.01, ***p < 0.001. In all cases, low group was used as referent. aIn case of hypo-HDL-cholesterolemia, the lowering of the ORs were evaluated
Similar content being viewed by others
Data availability
Raw data are not openly available but can be made available from the corresponding author upon reasonable request.
Code availability
Not applicable.
References
Afridi HI, Kazi TG, Kazi N, Kandhro GA, Baig JA, Shah AQ, Jamali MK, Arain MB (2010) Evaluation of toxic elements in scalp hair samples of myocardial infarction patients at different stages as related to controls. Biol Trace Elem Res 134:1–12. https://doi.org/10.1007/s12011-009-8450-6
Ahsan H, ChenY PF, Zablotska L, Argos M, Hussain I, Momotaj H, Levy D, Cheng Z, Slavkovich V, van Geen A, Howe GR, Graziano JH (2006) Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the health effects of arsenic longitudinal study. Am J Epidemiol 163:1138–1148. https://doi.org/10.1093/aje/kwj154
Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, Jasmine F, Gamble MV, Graziano JH (2007) Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev 16:1270–1278. https://doi.org/10.1158/1055-9965.EPI-06-0676
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Jr, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
Ali N, Hoque MA, Haque A, Salam KA, Karim MR, Rahman A, Islam K, Saud ZA, Khalek MA, Akhand AA, Hossain M, Mandal A, Karim MR, Miyataka H, Himeno S, Hossain K (2010) Association between arsenic exposure and plasma cholinesterase activity: a population based study in Bangladesh. Environ Health 9:1–9. https://doi.org/10.1186/1476-069X-9-36
BGS, DPHE (2001) Arsenic contamination of groundwater in Bangladesh. In: Kinniburgh DG, Smedley PL (eds) Volume 2: final report British Geological Survey Report WC/00/19 British Geological Survey, Keyworth. https://www2.bgs.ac.uk/arsenic/bangladesh/. Accessed 28 May 2021
Bulka CM, Mabila SL, Lash JP, Turyk ME, Argos M (2017) Arsenic and obesity: a comparison of urine dilution adjustment methods. Environ Health Perspect 125:087020. https://doi.org/10.1289/EHP1202
Bulka CM, Persky VW, Daviglus ML, Durazo-Arvizu RA, Argos M (2019) Multiple metal exposures and metabolic syndrome: a cross-sectional analysis of the National Health and Nutrition Examination Survey 2011–2014. Environ Res 168:397–405. https://doi.org/10.1016/j.envres.2018.10.022
Chatterjee A, Chatterji U (2010) Arsenic abrogates the estrogen-signaling pathway in the rat uterus. Reprod Biol Endocrinol 8:1–11. https://doi.org/10.1186/1477-7827-8-80
Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, Argos M, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Levy D, van Geen A, Ahsan H (2011) Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ. https://doi.org/10.1136/bmj.d2431
Chen JW, Wang SL, Wang YH, Sun CW, Huang YL, Chen CJ, Li WF (2012) Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in an arseniasis endemic area of southwestern Taiwan. Chemosphere 88:432–438. https://doi.org/10.1016/j.chemosphere.2012.02.059
Cheng TJ, Ke DS, Guo HR (2010) The association between arsenic exposure from drinking water and cerebrovascular disease mortality in Taiwan. Water Res 44:5770–5776. https://doi.org/10.1016/j.watres.2010.05.040
D’Ippoliti D, Santelli E, De Sario M, Scortichini M, Davoli M, Michelozzi P (2015) Arsenic in drinking water and mortality for cancer and chronic diseases in central Italy, 1990–2010. PLoS ONE 10:e0138182. https://doi.org/10.1371/journal.pone.0138182
Davey JC, Bodwell JE, Gosse JA, Hamilton JW (2007) Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor–mediated gene expression in vivo and in cell culture. Toxicol Sci 98:75–86. https://doi.org/10.1093/toxsci/kfm013
Després JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881–887. https://doi.org/10.1038/nature05488
Engel RR, Smith AH (1994) Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch Environ Health 49:418–427. https://doi.org/10.1080/00039896.1994.9954996
Fleckman P (1985) Anatomy and physiology of the nail. Dermatol Clin 3:373–381. https://doi.org/10.1016/S0733-8635(18)30874-X
Ford ES (2005) Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28:1769–1778. https://doi.org/10.2337/diacare.28.7.1769
Gerdts E, Regitz-Zagrosek V (2019) Sex differences in cardiometabolic disorders. Nat Med 25:1657–1666. https://doi.org/10.1038/s41591-019-0643-8
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F, American Heart Association, National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
Haffner SM (2006) The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97:3–11. https://doi.org/10.1016/j.amjcard.2005.11.010
Hall EM, Acevedo J, López FG, Cortés S, Ferreccio C, Smith AH, Steinmaus CM (2017) Hypertension among adults exposed to drinking water arsenic in Northern Chile. Environ Res 153:99–105. https://doi.org/10.1016/j.envres.2016.11.016
Harkey MR (1993) Anatomy and physiology of hair. Forensic Sci Int 63:9–18. https://doi.org/10.1016/0379-0738(93)90255-9
Hasibuzzaman MM, Hossain S, Islam MS, Rahman A, Anjum A, Hossain F, Mohanto NC, Karim MR, Hoque MM, Saud ZA, Miyataka H, Himeno S, Hossain K (2017) Association between arsenic exposure and soluble thrombomodulin: a cross sectional study in Bangladesh. PLoS ONE 12:e0175154. https://doi.org/10.1371/journal.pone.0175154
Hossain E, Islam K, Yeasmin F, Karim MR, Rahman M, Agarwal S, Hossain S, Aziz A, Al Mamun A, Sheikh A, Haque A, Hossain MT, Hossain M, Haris PI, Ikemura N, Inoue K, Miyataka H, Himeno S, Hossain K (2012) Elevated levels of plasma big endothelin-1 and its relation to hypertension and skin lesions in individuals exposed to arsenic. Toxicol Appl Pharmacol 259:187–194. https://doi.org/10.1016/j.taap.2011.12.023
Hossain K, Suzuki T, Hasibuzzaman MM, Islam MS, Rahman A, Paul SK, Tanu T, Hossain S, Saud ZA, Rahman M, Nikkon F, Miyataka H, Himeno S, Nohara K (2017) Chronic exposure to arsenic, LINE-1 hypomethylation, and blood pressure: a cross-sectional study in Bangladesh. Environ Health 16:20. https://doi.org/10.1186/s12940-017-0231-7
Huang CF, Yang CY, Chan DC, Wang CC, Huang KH, Wu CC, Tsai KS, Yang RS, Liu SH (2015) Arsenic exposure and glucose intolerance/insulin resistance in estrogen-deficient female mice. Environ Health Perspect 123:1138–1144. https://doi.org/10.1289/ehp.1408663
Huda N, Hossain S, Rahman M, Karim MR, Islam K, Mamun AA, Hossain MI, Mohanto NC, Alam S, Aktar S, Arefin A, Ali N, Salam KA, Aziz A, Saud ZA, Miyataka H, Himeno S, Hossain K (2014) Elevated levels of plasma uric acid and its relation to hypertension in arsenic-endemic human individuals in Bangladesh. Toxicol Appl Pharmacol 281:11–18. https://doi.org/10.1016/j.taap.2014.09.011
Islam MS, Mohanto NC, Karim MR, Aktar S, Hoque MM, Rahman A, Jahan M, Khatun R, Aziz A, Salam KA, Saud ZA, Hossain M, Rahman A, Mandal A, Haque A, Miyataka H, Himeno S, Hossain K (2015) Elevated concentrations of serum matrix metalloproteinase-2 and-9 and their associations with circulating markers of cardiovascular diseases in chronic arsenic-exposed individuals. Environ Health 14:92. https://doi.org/10.1186/s12940-015-0079-7
Karim MR, Rahman M, Islam K, Mamun AA, Hossain S, Hossain E, Aziz A, Yeasmin F, Agarwal S, Hossain MI, Saud ZA, Nikkon F, Hossain M, Mandal A, Jenkins RO, Haris PI, Miyataka H, Himeno S, Hossain K (2013) Increases in oxidized low-density lipoprotein and other inflammatory and adhesion molecules with a concomitant decrease in high-density lipoprotein in the individuals exposed to arsenic in Bangladesh. Toxicol Sci 135:17–25. https://doi.org/10.1093/toxsci/kft130
Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN (2005) Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care 28:391–397. https://doi.org/10.2337/diacare.28.2.391
Kazemifar AM, Shafikhani AA, Mozhdehipanah H, Khamesi S, Arami M (2020) Evaluation of different types of arsenic methylation and its relationship with metabolic syndrome in an area chronically exposed to arsenic. Environ Anal Health Toxicol 35:e2020006. https://doi.org/10.5620/eaht.e2020006
Kile ML, Hoffman E, Rodrigues EG, Breton CV, Quamruzzaman Q, Rahman M, Mahiuddin G, Hsueh YM, Christiani DC (2011) A pathway-based analysis of urinary arsenic metabolites and skin lesions. Am J Epidemiol 173:778–786. https://doi.org/10.1093/aje/kwq427
Kuo CC, Moon KA, Wang SL, Silbergeld E, Navas-Acien A (2017) The association of arsenic metabolism with cancer, cardiovascular disease, and diabetes: a systematic review of the epidemiological evidence. Environ Health Perspect 125:087001. https://doi.org/10.1289/EHP577
Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL (1999) Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect 107:359–365. https://doi.org/10.1289/ehp.99107359
Lind PM, Lind L (2018) Endocrine-disrupting chemicals and risk of diabetes: an evidence-based review. Diabetologia 61:1495–1502. https://doi.org/10.1007/s00125-018-4621-3
Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR, Williams GR (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110:1245–1250. https://doi.org/10.1161/01.CIR.0000140677.20606.0E
Meharg AA, Rahman MM (2003) Arsenic contamination of Bangladesh paddy field soils: implications for rice contribution to arsenic consumption. Environ Sci Technol 37:229–234. https://doi.org/10.1021/es0259842
Meharg AA, Williams PN, Deacon CM, Norton GJ, Hossain M, Louhing D, Marwa E, Lawgalwi Y, Taggart M, Cascio C, Haris P (2014) Urinary excretion of arsenic following rice consumption. Environ Pollut 194:181–187. https://doi.org/10.1016/j.envpol.2014.07.031
Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D’Agostino RB (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91:2906–2912. https://doi.org/10.1210/jc.2006-0594
Meliker JR, Wahl RL, Cameron LL, Nriagu JO (2007) Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ Health 6:1–11. https://doi.org/10.1186/1476-069X-6-4
Mondal V, Hosen Z, Hossen F, Siddique AE, Tony SR, Islam Z, Islam MS, Hossain S, Islam K, Sarker MK, Hasibuzzaman MM, Liu LZ, Jiang BH, Hoque MM, Saud ZA, Xin L, Himeno S, Hossain K (2020) Arsenic exposure-related hyperglycemia is linked to insulin resistance with concomitant reduction of skeletal muscle mass. Environ Int 143:105890. https://doi.org/10.1016/j.envint.2020.105890
Moon K, Guallar E, Navas-Acien A (2012) Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep 14:542–555. https://doi.org/10.1007/s11883-012-0280-x
Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ (2010) The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol 56:1113–1132. https://doi.org/10.1016/j.jacc.2010.05.034
Pace C, Smith-Gagen J, Angermann J (2018) Arsenic methylation capacity and metabolic syndrome in the 2013–2014 US National Health and Nutrition Examination Survey (NHANES). Int J Environ Res Public Health 15:168. https://doi.org/10.3390/ijerph15010168
Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB (2003) The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 163:427–436. https://doi.org/10.1001/archinte.163.4.427
Patel P, Abate N (2013) Body fat distribution and insulin resistance. Nutrients 5:2019–2027. https://doi.org/10.3390/nu5062019
Paul SK, Islam MS, Hasibuzzaman MM, Hossain F, Anjum A, Saud ZA, Haque MM, Sultana P, Haque A, Andric KB, Rahman A, Karim MR, Siddique AE, Karim Y, Rahman M, Miyataka H, Xin L, Himeno S, Hossain K (2019) Higher risk of hyperglycemia with greater susceptibility in females in chronic arsenic-exposed individuals in Bangladesh. Sci Total Environ 668:1004–1012. https://doi.org/10.1016/j.scitotenv.2019.03.029
Rader DJ, Hovingh GK (2014) HDL and cardiovascular disease. Lancet 384:618–625. https://doi.org/10.1016/S0140-6736(14)61217-4
Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, Axelson O (1999) Hypertension arsenic exposure in Bangladesh. Hypertension 33:74–78. https://doi.org/10.1161/01.hyp.33.1.74
Rahman M, Vahter M, Wahed MA, Sohel N, Yunus M, Streatfield PK, El Arifeen S, Bhuiya A, Zaman K, Chowdhury AM, Ekström EC, Persson LA (2006) Prevalence of arsenic exposure and skin lesions. A population based survey in Matlab. Bangladesh J Epidemiol Community Health 60:242–248. https://doi.org/10.1136/jech.2005.040212
Rahman M, Sohel N, Yunus M, Chowdhury ME, Hore SK, Zaman K, Bhuiya A, Streatfield PK (2014) A prospective cohort study of stroke mortality and arsenic in drinking water in Bangladeshi adults. BMC Public Health 14:174. https://doi.org/10.1186/1471-2458-14-174
Rahman M, Al Mamun A, Karim MR, Islam K, Al Amin H, Hossain S, Hossain MI, Saud ZA, Noman AS, Miyataka H, Himeno S, Hossain K (2015) Associations of total arsenic in drinking water, hair and nails with serum vascular endothelial growth factor in arsenic-endemic individuals in Bangladesh. Chemosphere 120:336–342. https://doi.org/10.1016/j.chemosphere.2014.08.003
Rahman M, Sohel N, Yunus FM, Alam N, Nahar Q, Streatfield PK, Yunus M (2019) Arsenic exposure and young adult’s mortality risk: A 13-year follow-up study in Matlab, Bangladesh. Environ Int 123:358–367. https://doi.org/10.1016/j.envint.2018.12.006
Rancière F, Botton J, Slama R, Lacroix MZ, Debrauwer L, Charles MA, Roussel R, Balkau B, Magliano DJ, D.E.S.I.R. Study Group (2019) Exposure to bisphenol A and bisphenol S and incident type 2 diabetes: a case–cohort study in the French cohort DESIR. Environ Health Perspect 127:107013.https://doi.org/10.1289/EHP5159
Razzouk L, Muntner P (2009) Ethnic, gender, and age-related differences in patients with the metabolic syndrome. Curr Hypertens Rep 11:127–132. https://doi.org/10.1007/s11906-009-0023-8
Rhee SY, Hwang YC, Woo JT, Sinn DH, Chin SO, Chon S, Kim YS (2013) Blood lead is significantly associated with metabolic syndrome in Korean adults: an analysis based on the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. Cardiovasc Diabetol 12:1–7. https://doi.org/10.1186/1475-2840-12-9
Rotter I, Kosik-Bogacka D, Dołęgowska B, Safranow K, Lubkowska A, Laszczyńska M (2015) Relationship between the concentrations of heavy metals and bioelements in aging men with metabolic syndrome. Int J Environ Res Public Health 12:3944–3961. https://doi.org/10.3390/ijerph120403944
Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M (2006) Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. BMC Public Health 6:1–6. https://doi.org/10.1186/1471-2458-6-92
Schmitt MT, Schreinemachers D, Wu K, Ning Z, Zhao B, Le XC, Mumford JL (2005) Human nails as a biomarker of arsenic exposure from well water in Inner Mongolia: comparing atomic fluorescence spectrometry and neutron activation analysis. Biomarkers 10:95–104. https://doi.org/10.1080/13547500500087913
Siddique AE, Rahman M, Hossain MI, Karim Y, Hasibuzzaman MM, Biswas S, Islam MS, Rahman A, Hossen F, Mondal V, Banna HU, Huda N, Hossain M, Sultana P, Nikkon F, Saud ZA, Haque A, Nohara K, Xin L, Himeno S, Hossain K (2020) Association between chronic arsenic exposure and the characteristic features of asthma. Chemosphere 246:125790. https://doi.org/10.1016/j.chemosphere.2019.125790
Slagter SN, van Waateringe RP, van Beek AP, van der Klauw MM, Wolffenbuttel BH, van Vliet-Ostaptchouk JV (2017) Sex, BMI and age differences in metabolic syndrome: the Dutch Lifelines Cohort Study. Endocr Connect 6:278–288. https://doi.org/10.1530/EC-17-0011
Smith AH, Goycolea M, Haque R, Biggs ML (1998) Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol 147:660–669. https://doi.org/10.1093/oxfordjournals.aje.a009507
Spratlen MJ, Grau-Perez M, Best LG, Yracheta J, Lazo M, Vaidya D, Balakrishnan P, Gamble MV, Francesconi KA, Goessler W, Cole SA, Umans JG, Howard BV, Navas-Acien A (2018) The association of arsenic exposure and arsenic metabolism with the metabolic syndrome and its individual components: prospective evidence from the Strong Heart Family Study. Am J Epidemiol 187:1598–1612. https://doi.org/10.1093/aje/kwy048
Sun K, Liu J, Ning G (2012) Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLoS ONE 7:e47791. https://doi.org/10.1371/journal.pone.0047791
Tan CE, Ma S, Wai D, Chew SK, Tai ES (2004) Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27:1182–1186. https://doi.org/10.2337/diacare.27.5.1182
Thorn LM, Forsblom C, Wadén J, Saraheimo M, Tolonen N, Hietala K, Groop PH, Finnish Diabetic Nephropathy (FinnDiane) Study Group (2009) Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 32:950–952. https://doi.org/10.2337/dc08-2022
Vahter M, Åkesson A, Liden C, Ceccatelli S, Berglund M (2007) Gender differences in the disposition and toxicity of metals. Environ Res 104:85–95. https://doi.org/10.1016/j.envres.2006.08.003
Veenema R, Casin KM, Sinha P, Kabir R, Mackowski N, Taube N, Bedja D, Chen R, Rule A, Kohr MJ (2019) Inorganic arsenic exposure induces sex-disparate effects and exacerbates ischemia-reperfusion injury in the female heart. Am J Physiol Heart Circ Physiol 316:H1053–H1064. https://doi.org/10.1152/ajpheart.00364.2018
Wang SL, Chang FH, Liou SH, Wang HJ, Li WF, Hsieh DP (2007) Inorganic arsenic exposure and its relation to metabolic syndrome in an industrial area of Taiwan. Environ Int 33:805–811. https://doi.org/10.1016/j.envint.2007.03.004
Watanabe C, Inaoka T, Kadono T, Nagano M, Nakamura S, Ushijima K, Murayama N, Miyazaki K, Ohtsuka R (2001) Males in rural Bangladeshi communities are more susceptible to chronic arsenic poisoning than females: analyses based on urinary arsenic. Environ Health Perspect 109:1265–1270. https://doi.org/10.1289/ehp.011091265
Watson WH, Yager JD (2007) Arsenic: extension of its endocrine disruption potential to interference with estrogen receptor-mediated signaling. Toxicol Sci 98:1–4. https://doi.org/10.1093/toxsci/kfm111
Williams PN, Islam MR, Adomako EE, Raab A, Hossain SA, Zhu YG, Feldmann J, Meharg AA (2006) Increase in rice grain arsenic for regions of Bangladesh irrigating paddies with elevated arsenic in groundwaters. Environ Sci Technol 40:4903–4908. https://doi.org/10.1021/es060222i
World Health Organization (2011) Waist circumference and waist-hip ratio. Report of a WHO Expert Consultation. Geneva: World Health Organization. https://apps.who.int/iris/handle/10665/44583. Accessed 28 May 2021
World Health Organization (2018) Arsenic. Geneva, World Health Organization (WHO) Fact Sheet. https://www.who.int/en/news-room/fact-sheets/detail/arsenic. Accessed 26 Sept 2021
Wu MM, Kuo TL, Hwang YH, Chen CJ (1989) Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130:1123–1132. https://doi.org/10.1093/oxfordjournals.aje.a115439
Xu P, Liu A, Li F, Tinkov AA, Liu L, Zhou JC (2021) Associations between metabolic syndrome and four heavy metals: a systematic review and meta-analysis. Environ Pollut 273:116480. https://doi.org/10.1016/j.envpol.2021.116480
Yang CY, Chiu HF, Chang CC, Ho SC, Wu TN (2005) Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan. Environ Res 98:127–132. https://doi.org/10.1016/j.envres.2004.07.013
Yang BY, Qian Z, Howard SW, Vaughn MG, Fan SJ, Liu KK, Dong GH (2018) Global association between ambient air pollution and blood pressure: a systematic review and meta-analysis. Environ Pollut 235:576–588. https://doi.org/10.1016/j.envpol.2018.01.001
Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, Bates MN, Smith AH (2007) Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol 166:1381–1391. https://doi.org/10.1093/aje/kwm238
Zheutlin AR, Hu H, Weisskopf MG, Sparrow D, Vokonas PS, Park SK (2018) Low-level cumulative lead and resistant hypertension: a prospective study of men participating in the Veterans Affairs Normative Aging Study. J Am Heart Assoc 7:e010014. https://doi.org/10.1161/JAHA.118.010014
Funding
This work was partially funded by three JSPS KAKENHI Grants [Nos. 16H05834, 24310048 and 19K12346], the Ministry of Science and Technology, Government of the People’s Republic of Bangladesh [Grant No. 39.009.006.01.00.042.2012-2013/ES-21/558] and two Grants from Rajshahi University [Nos. 5/52/RU/Science-13/17-18 and 5/52/RU/Science-32/20-21].
Author information
Authors and Affiliations
Contributions
Conceptualization: MKS, KH; Writing—Original Draft preparation: MKS; Methodology: KH; Formal analysis: SRT, AES; Investigation; MKS, SRT, AES, FH, ZI, MAH; Data Curation; MSI; Visualization: NH; Writing—Review & Editing: SH, KH; Funding acquisition: SH, DS, KH; Resources: ZAS, SH; Supervision; KH.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Ethics approval
Institute of Biological Sciences (IBSc) (no. 661/320/IAMEBBC/IBSc), University of Rajshahi approved this study.
Consent to participate
Written consent from each human subject was taken prior to his/her participation in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sarker, M.K., Tony, S.R., Siddique, A.E. et al. Gender Differences in the Risk of Metabolic Syndrome Among Chronic Arsenic-Exposed Individuals in Bangladesh. Expo Health 14, 595–608 (2022). https://doi.org/10.1007/s12403-021-00437-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12403-021-00437-1